Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, G.
Right arrow Articles by Skarin, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, G.
Right arrow Articles by Skarin, A. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 17, Issue 6 (June), 1999: 1956
© 1999 American Society for Clinical Oncology


DIAGNOSIS IN ONCOLOGY

Gynecomastia in a Patient With Lung Cancer

Arthur Skarin, MD, Consultant Editor

Geoffrey Liu, Marla L. Rosenfield Darling, Jennifer Chan, Michael T. Jaklitsch, Arthur T. Skarin

Department of Adult Oncology, Dana-Farber Cancer Institute; Departments of Medicine, Surgery, Radiology, and Pathology, Brigham and Women's Hospital; and Harvard Medical School, Boston, MA

A 45-year-old man presented with bilateral gynecomastia and galactorrhea. He was a 65 pack-year tobacco smoker, smoked half a joint of marijuana per day chronically, and used crack cocaine twice per week on average. He denied use of other medications, supplements, or hormones. Physical examination showed slightly enlarged breasts with a milky discharge from both nipples. There was no adenopathy, and testicular examination was normal. The patient had a serum beta-human chorionic gonadotropin (ßHCG) level of 8609 ng/mL (normally undetectable) and a prolactin level of 68 µg/L (normal, < 25 µg/L). A preoperative chest computed tomography (CT) scan showed a 2.5-cm mass posteriorly in the right upper lobe (Fig 1). A right upper lobectomy was performed. Pathology revealed a poorly differentiated large-cell carcinoma, with extensive necrosis and hemorrhage (Fig 2A and 2B). The tumor cells stained positive for LeuM1 and focally positive for carcinoembryonic antigen (CEA), but they were negative for alpha-fetoprotein. Scattered large, anaplastic, multinucleated cells showed ßHCG and placental alkaline phosphatase positivity on immunoperoxidase staining (Fig 2C). One month after surgery, the ßHCG level was 247 ng/mL and the prolactin level was normal. The nipple discharge was now watery. Four months later, the patient presented with increasing dyspnea and hemoptysis. Innumerable bilateral pulmonary nodules were present on follow-up CT scan of the chest, ranging in size from 0.5 to 1.5 cm (Fig 3A). Many of the nodules were surrounded by a halo of ground-glass opacity consistent with hemorrhage (Fig 3A, arrow). On an abdominal CT scan, a right adrenal mass was present that was consistent with metastatic disease. The ßHCG level was 5,878 ng/mL, and he had a normal prolactin level. One week later, he developed excruciating right upper quadrant abdominal pain with a benign physical examination. A repeat noncontrast CT scan of the abdomen showed heterogenous enlargement of the right adrenal mass (increased to 5.9 x 5 cm), with new regions of high attenuation peripherally consistent with hemorrhage (Fig 3B, arrow). Against medical advice, the patient left the hospital and refused systemic treatment.



View larger version (74K):
[in this window]
[in a new window]
 
Fig 1.

 


View larger version (87K):
[in this window]
[in a new window]
 
Fig 2.

 


View larger version (49K):
[in this window]
[in a new window]
 
Fig 3.

 

In this patient, hemorrhagic metastases, an elevated serum ßHCG level, and positive ßHCG in multinucleated tumor cells are compatible with choriocarcinomatous differentiation. In addition, a single large adrenal metastasis, positive CEA and LeuM1 immunostaining, and histology showing a continuum of cell sizes and degrees of anaplasia (as opposed to a two-cell population of cyto- and syncytiotrophoblastic cells) favor a primary lung cancer over a primary germ cell tumor.

Although gynecomastia has been documented in non–small-cell lung cancers (NSCLC), variably elevated ßHCG levels are detected in up to half of patients with NSCLC in either serum or urine using sensitive assays and may be a poor prognostic marker.1,2 It is unusual for these elevations to result in clinical features. Large-cell lung carcinomas immunostain for ßHCG more frequently than other NSCLCs.3 ßHCG mRNA transcripts are demonstrated in some NSCLCs and not in controls.4 Of note, elevated ßHCG levels and gynecomastia have been documented with marijuana use.5 In this patient, the primary tumor contained ßHCG immunoreactivity, and ßHCG level fluctuations corresponded closely to the tumor burden and not to his marijuana use. Galactorrhea is extremely rare in NSCLC. Subclinical elevations in prolactin have been described in a minority of NSCLCs.6 Modest elevations in prolactin levels (< 100 µg/mL) have been associated with chronic cocaine use and cocaine withdrawal in addicts,7 and may have contributed to this unusual presentation of lung cancer.

REFERENCES

1. Goldstein DP, Kossa TS, Skarin A: The clinical application of a specific radioimmunoassay for human chorionic gonadotropin in trophoblastic and nontrophoblastic tumors. Surg Gynecol Oncol 148:747-751, 1974

2. Yoshimura M, Nishimura R, Murotani A, et al: Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer. Cancer 73:2745-2752, 1994[Medline]

3. Boucher LD, Yoneda K: The expression of trophoblastic cell markers by lung carcinomas. Hum Pathol 26:1201-1206, 1995[Medline]

4. Yokotani T, Koizumi T, Taniguchi R, et al: Expression of alpha and beta genes of human chorionic gonadotropin in lung cancer. Int J Cancer 71:539-544, 1997[Medline]

5. Garnick MB: Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer. N Engl J Med 303:1177, 1980 (letter)[Medline]

6. Gropp C, Havemann K, Scheuer A: Ectopic hormones in lung cancer patients at diagnosis and during therapy. Cancer 46:340-346, 1980[Medline]

7. Mendelson JH, Mello NK, Teoh SK, et al: Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. J Clin Endocrinol Metab 69:1256-1260, 1989[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, G.
Right arrow Articles by Skarin, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, G.
Right arrow Articles by Skarin, A. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1999 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online